Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details)

v3.20.1
Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Summary of Significant Accounting Policies (Textual)    
Common stock subject to possible redemption, shares 33,618 10,778,788
Description of net income (loss) per common share The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and Private Placement to purchase 6,001,250 shares of common stock and (2) rights sold in the Initial Public Offering and Private Placement that convert into 1,200,250 shares of common stock, in the calculation of diluted income per share, since the exercise of the warrants and the conversion of the rights into shares of common stock is contingent upon the occurrence of future events and the inclusion of such warrants and rights would be anti-dilutive under the treasury stock method.  
Federal depository insurance coverage amount $ 250,000 $ 250,000
Cash and marketable securities held in trust account   1,700
U.S. Treasury Bills 11,877,654 118,164,248
Deferred tax assets
Deferred tax assets, Valuation allowance $ 407,368 $ 161,558